MedTrace Logo

Clinical Trial of Pregabalin and COX2 in Spinal Stenosis

NCT03584074 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-07-12

No results posted yet for this study

Summary

Aim of this prospective, single-blind, randomized study was to compare the efficacy of the combination of celecoxib and pregabalin and celecoxib only monotherapy for treatment of chronic low-back pain.

Conditions

  • Spinal Stenosis Lumbar

Interventions

DRUG

Pregabalin 75mg

Orally taken twice daily for 8 weeks

DRUG

Celebrex 200Mg Capsule

Orally taken once daily for 8 weeks

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-05-30
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03584074 on ClinicalTrials.gov